NGNE Earnings Date: Nov 12, 2026 (Estimated) — Neurogene Inc.
NASDAQ
Updated
When is NGNE's next earnings date?
Neurogene Inc. (NGNE) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.49.
How did NGNE do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Neurogene Inc. posted EPS of -$1.53 versus the -$1.42 estimate, a miss of 10.9%. Revenue was $0. The stock's 1-day post-earnings move was -2.1%.
How much does NGNE stock move after earnings?
NGNE beat EPS estimates in 4 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 6.3% (up or down) in the day after earnings.
About Neurogene Inc.
Neurogene Inc. is dedicated to engineering transformative genetic treatments for individuals and their families grappling with debilitating neurological conditions. Its current pipeline prominently features two key investigational therapies: NGN-401, an AAV9 gene therapy specifically targeting Rett syndrome, and NGN-101, which is being developed to address neuronal ceroid lipofuscinosis subtype 5 (Batten disease). The company's operations are based in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -1.42 | -1.53 | -10.87% | $0 | ❌ Miss | -2.05% | +0.36% | +3.64% |
| 2026-05-12 | Q1 2026 | -1.29 | -1.39 | -7.75% | $0 | ❌ Miss | +3.42% | -14.77% | -8.05% |
| 2026-03-24 | Q4 2025 | -1.21 | -1.13 | +6.61% | $0 | ✅ Beat | +7.95% | -0.31% | +40.86% |
| 2025-11-13 | Q3 2025 | -1.16 | -0.99 | +14.66% | $0 | ✅ Beat | -14.04% | -22.99% | -23.52% |
| 2025-08-11 | Q2 2025 | -1.09 | -1.05 | +3.67% | $0 | ✅ Beat | -5.55% | +0.49% | -8.60% |
| 2025-03-24 | Q4 2024 | — | -1.00 | — | $0 | — | +1.72% | -16.12% | +10.60% |
| 2024-11-18 | Q3 2024 | -1.22 | -1.19 | +2.46% | $0 | ✅ Beat | -13.07% | +12.59% | +9.94% |
| 2024-08-09 | Q2 2024 | -1.05 | -1.09 | -3.81% | $925,000 | ❌ Miss | -2.63% | -2.54% | -3.89% |
Showing last 8 quarters.